The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer

Expert Consensus Panel; Biniam Kidane; Matthew Bott; Jonathan Spicer; Leah Backhus; Jamie Chaft; Neel Chudgar; Yolonda Colson; Thomas A D'Amico; Elizabeth David; Jay Lee; Sara Najmeh; Boris Sepesi; Catherine Shu; Jeffrey Yang; Scott Swanson; Brendon Stiles

doi:10.1016/j.jtcvs.2023.04.039

The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer

J Thorac Cardiovasc Surg. 2023 Sep;166(3):637-654. doi: 10.1016/j.jtcvs.2023.04.039. Epub 2023 Jun 10.

Authors

Expert Consensus Panel; Biniam Kidane¹, Matthew Bott², Jonathan Spicer³, Leah Backhus⁴, Jamie Chaft², Neel Chudgar⁵, Yolonda Colson⁶, Thomas A D'Amico⁷, Elizabeth David⁸, Jay Lee⁹, Sara Najmeh³, Boris Sepesi¹⁰, Catherine Shu¹¹, Jeffrey Yang⁶, Scott Swanson¹², Brendon Stiles¹³

Affiliations

¹ University of Manitoba, Winnipeg, Manitoba, Canada.
² Memorial Sloan-Kettering Cancer Center, New York, NY.
³ McGill University, Montreal, Quebec, Canada.
⁴ Stanford University, Palo Alto, Calif.
⁵ Albert Einstein College of Medicine, Bronx, NY.
⁶ Massachusetts General Hospital, Boston, Mass.
⁷ Duke Cancer Institute, Durham, NC.
⁸ University of Colorado, Denver, Colo.
⁹ University of California, Los Angeles, Los Angeles, Calif.
¹⁰ MD Anderson Cancer Center, Houston, Tex.
¹¹ Columbia University, New York, NY.
¹² Brigham and Women's Hospital, Boston, Mass.
¹³ Albert Einstein College of Medicine, Bronx, NY. Electronic address: brstiles@montefiore.org.

PMID: 37306641
DOI: 10.1016/j.jtcvs.2023.04.039

Abstract

Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.

Keywords: adjuvant; clinical staging; immunotherapy; neoadjuvant; non–small cell lung cancer; surgery; targeted therapy.

Publication types

Practice Guideline

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / surgery
Consensus
Humans
Immunotherapy
Lung Neoplasms* / drug therapy
Lung Neoplasms* / surgery
Neoadjuvant Therapy
Neoplasm Staging
Small Cell Lung Carcinoma*
Thoracic Surgery*
United States